Subutex is a brand name for buprenorphine hydrochloride, a medication primarily used in opioid use disorder (OUD) treatment. It’s a partial opioid agonist, meaning it activates opioid receptors in the brain but to a lesser extent than full agonists like heroin or oxycodone, helping to reduce cravings and withdrawal symptoms without producing a strong “high.”

Key Facts and Uses

• Primary Use: Medication-assisted treatment (MAT) for opioid addiction. It’s often prescribed as part of a comprehensive program including counseling.
• Form: Sublingual tablets (dissolved under the tongue). Common strengths: 2 mg, 8 mg.
• How It Works:

• Comparison to Similar Drugs:

Dosage and Administration (Typical Adult)

• Induction: Start with 2–4 mg on Day 1, up to 8–16 mg/day.
• Maintenance: 8–24 mg/day, adjusted based on response.
• Evidence: Supported by studies like the 2009 NEJM trial showing buprenorphine reduces illicit opioid use by 50–70% vs. placebo.

Side Effects and Risks

• Overdose Risk: Lower than full opioids, but still possible. Naloxone reverses it.
• Pregnancy: Category C; used safely in neonatal abstinence syndrome prevention (evidence from MOTHER study).

Legal and Availability

• Controlled Substance: Schedule III in the US (DEA).
• Prescription: Requires special waiver (e.g., DATA 2000 for physicians). Not for pain relief primarily—use Belbuca or generics for that.
• Street Context: Often diverted/abused sublingually or IV. Street prices: $1–2/mg (per DEA reports).

Warnings

• Do not use with: Alcohol, sedatives, or other opioids—increases overdose risk (CDC data: 30% of opioid ODs involve benzos).
• Tapering: Abrupt stop causes withdrawal; taper slowly.
• Source: FDA-approved (1990s); info from FDA label, NIH, SAMHSA guidelines.

If you’re seeking it for treatment, consult a doctor or SAMHSA hotline (1-800-662-HELP). Not medical advice—always verify with a professional. Need more details (e.g., interactions, studies)? Ask!